Results 51 to 60 of about 4,463 (213)

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study—TCOG T1214 study

Cancer, Volume 131, Issue 17, 1 September 2025.
Abstract Background Gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs) account for more than 50% of all NENs. The survival of patients with GEP‐NENs has improved based on early diagnosis and improved treatment strategies. The real‐world data of GEP‐NENs in Taiwan are limited.
Hui‐Jen Tsai, Ming‐Huang Chen, Hsiu‐Po Wang, Chin‐Fu Hsiao, Yen‐Yang Chen, Jen‐Shi Chen, Mei‐Due Yang, Chin‐Yuan Tzen, Yan‐Shen Shan, Li‐Yaun Bai, De‐Chuan Chan, Pei‐Yi Chu, Ching‐Liang Ho, Youngsen Yang, Johnson Lin, Hsuan‐Yu Lin, Cheng‐Shyong Chang, Chuan‐Cheng Wang, Tsann‐Long Hwang, Li‐Tzong Chen   +19 more
wiley   +1 more source

Gastrinoma tem ocorrência incomum na faixa etária pediátrica. Relato de um caso

Acta Gastroenterológica Latinoamericana, 2012
Los autores presentan los hallazgos clínicos, de laboratorio y radiológicos sugerentes de gastrinoma en un paciente de 1 año y 9 meses. Las pruebas de laboratorio obtenidas después de un ayuno revelaron una gastri - na sérica elevada, apoyando el ...
Guilherme Endrigo Fernandes, Tatiana Larissa Medeiros Arcanjo, Nubia Mendonça, Jose Henrique Silva Barreto   +3 more
doaj  

Differences in Endoscopic Features of Gastric Neuroendocrine Tumor and Neuroendocrine Carcinoma From a Clinicopathological Perspective

JGH Open, Volume 9, Issue 9, September 2025.
ABSTRACT Gastric neuroendocrine neoplasms are a rare type of stomach cancer, classified into well‐differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Gastric NETs (G‐NETs) originate from endocrine progenitor cells in the basal layer of the mucosa, primarily in the setting of chronic atrophic gastritis,
Katsunori Matsueda, Noriya Uedo, Masanori Kitamura, Seiji Kawano, Motoyuki Otsuka   +4 more
wiley   +1 more source

Features of multiple endocrine neoplasia type 1 the patient 48 years (MEN-1 in a patient of 48)

Эндокринная хирургия, 2015
Given the unique observation of atypical MEN­1 (mixed version) of a man 48 years old, due to the presence 9 of multiple tumors and hyperplasia in 8 different organs (parathyroid glands, pancreatic and thyroid glands, duodenum, lung, stomach, skin and ...
Sergey Vladimirovich Sergуikо, Valeriy Alekseevich Privalov   +1 more
doaj   +1 more source

Nuclear medicine in endocrine tumours [PDF]

, 2011
C
Peremans, Kathelijne, Van De Wiele, Christophe   +1 more
core   +2 more sources

What is the quality of smoking cessation advice in guidelines of tobacco-related diseases? [PDF]

, 2015
Smoking is a major risk factor for a range of diseases, and quitting smoking provides considerable benefits to health. It therefore follows that clinical guidelines on disease management, particularly for diseases caused by smoking, should include ...
Agrawal, Sanjay, Bogdanovica, Ilze, Britton, John, Gregory, Benjamin, Leonardi-Bee, Jo, Tobacco Advisory Group of the Royal College of Physicians   +5 more
core   +1 more source

Cholecystokinin: Clinical aspects of the new biology

Journal of Internal Medicine, Volume 298, Issue 3, Page 251-267, September 2025.
Abstract Cholecystokinin (CCK) is a classic gut hormone that has been known for almost a century to regulate gallbladder emptying, pancreatic enzyme secretion, and gastrointestinal motor activity. In 1968, the CCK structure was identified by Viktor Mutt and Erik Jorpes from porcine gut extracts as a peptide of 33 amino acid residues.
Jens F. Rehfeld
wiley   +1 more source

Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome—over a decade of follow-up

World Journal of Surgical Oncology, 2019
Background Zollinger-Ellison syndrome (ZES) is a rare condition characterized by hypersecretion of gastrin by gastrinoma tumors leading to severe peptic ulcer disease with potential development of gastric carcinoid tumors.
Lynsey M. Daniels, Marian Khalili, William F. Morano, Michaela Simoncini, Beth C. Mapow, Andrea Leaf, Wilbur B. Bowne   +6 more
doaj   +1 more source

The management of neuroendocrine tumours: A nutritional viewpoint [PDF]

, 2017
Nutritional status in patients with neuroendocrine tumours (NETs), especially of gastroenteropancreatic origin, can be deeply affected by excessive production of gastrointestinal hormones, peptides, and amines, which can lead to malabsorption, diarrhoea,
Annamaria Colao, Antongiulio Faggiano, Genoveffa Pizza, Giovanna Muscogiuri, Luigi Barrea, Marco Gallo, null null, Rosaria Maddalena Ruggeri   +7 more
core   +1 more source

Type 2 and type 3 gastric neuroendocrine tumors have high risk of lymph node metastasis: Systematic review and meta‐analysis

Digestive Endoscopy, Volume 37, Issue 8, Page 834-843, August 2025.
Objectives Lymph node metastasis (LNM) is crucial in determining treatment strategies for gastric neuroendocrine tumors (gNETs). While type 3 is considered more aggressive than types 1 and 2 within the clinical subtype of gNETs, the supporting data were insufficient, due to their rarity. We aimed to study the prevalence and risk factors associated with
Yohei Ogata, Waku Hatta, Takeshi Kanno, Masahiro Saito, Xiaoyi Jin, Naoki Asano, Tomoyuki Koike, Akira Imatani, Yuhong Yuan, Atsushi Masamune   +9 more
wiley   +1 more source